date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.583247789529492.
The log-likelihood improved by 3.904.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.837.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1608.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       16     1264     1122      795      349      326      336 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     279      219      136       72       45       23       11        2 
degree17 
       1 
1 
disease_progression 
H-positive risk:  921 862 116 866 447 121 870 392 143 71 131 60 
H-negative risk:  862 921 870 866 392 447 121 116 131 143 60 71 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
52 new agents 
2 
disease_progression 
H-positive risk:  923 865 119 869 442 122 870 388 145 68 130 59 
H-negative risk:  865 923 870 869 388 442 122 119 130 145 59 68 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
61 new agents 
3 
disease_progression 
H-positive risk:  932 881 121 868 438 123 867 370 143 67 130 60 
H-negative risk:  881 932 867 868 370 438 123 121 130 143 60 67 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
4 
disease_progression 
H-positive risk:  927 889 124 871 435 124 872 364 143 65 130 56 
H-negative risk:  889 927 872 871 364 435 124 124 130 143 56 65 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
84 new agents 
5 
disease_progression 
H-positive risk:  934 890 125 865 434 130 871 363 143 63 130 52 
H-negative risk:  890 934 871 865 363 434 130 125 130 143 52 63 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 8 1 

clinical_engagement 
diagnosis 
demography 
51 new agents 
6 
disease_progression 
H-positive risk:  936 889 125 873 429 132 867 362 145 63 128 51 
H-negative risk:  889 936 867 873 362 429 132 125 128 145 51 63 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 7 1 

clinical_engagement 
diagnosis 
demography 
63 new agents 
7 
disease_progression 
H-positive risk:  939 897 127 873 420 133 862 363 143 62 131 50 
H-negative risk:  897 939 862 873 363 420 133 127 131 143 50 62 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 8 1 

clinical_engagement 
diagnosis 
demography 
55 new agents 
8 
disease_progression 
H-positive risk:  940 897 128 881 416 135 866 356 142 61 131 47 
H-negative risk:  897 940 866 881 356 416 135 128 131 142 47 61 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 10 1 

clinical_engagement 
diagnosis 
demography 
55 new agents 
9 
disease_progression 
H-positive risk:  947 904 127 878 412 137 863 354 140 60 131 47 
H-negative risk:  904 947 863 878 354 412 137 127 131 140 47 60 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 13 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
10 
disease_progression 
H-positive risk:  958 911 127 871 409 139 854 352 140 60 131 48 
H-negative risk:  911 958 854 871 352 409 139 127 131 140 48 60 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 16 1 

clinical_engagement 
diagnosis 
demography 
55 new agents 
11 
disease_progression 
H-positive risk:  959 915 129 867 401 140 857 349 142 61 132 48 
H-negative risk:  915 959 857 867 349 401 140 129 132 142 48 61 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 15 1 

clinical_engagement 
diagnosis 
demography 
49 new agents 
12 
disease_progression 
H-positive risk:  960 923 130 862 390 142 861 345 143 63 132 49 
H-negative risk:  923 960 861 862 345 390 142 130 132 143 49 63 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 15 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
13 
disease_progression 
H-positive risk:  881 865 119 926 390 129 946 338 153 61 145 47 
H-negative risk:  865 881 946 926 338 390 129 119 145 153 47 61 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 15 1 

clinical_engagement 
diagnosis 
demography 
226 new agents 
14 
disease_progression 
H-positive risk:  914 895 118 870 398 135 908 362 146 64 135 55 
H-negative risk:  895 914 908 870 362 398 135 118 135 146 55 64 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 26 1 

clinical_engagement 
diagnosis 
demography 
53 new agents 
15 
disease_progression 
H-positive risk:  918 896 119 869 394 135 907 363 145 62 137 55 
H-negative risk:  896 918 907 869 363 394 135 119 137 145 55 62 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 26 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
16 
disease_progression 
H-positive risk:  917 898 117 874 388 137 906 363 144 61 139 56 
H-negative risk:  898 917 906 874 363 388 137 117 139 144 56 61 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 24 1 

clinical_engagement 
diagnosis 
demography 
63 new agents 
17 
disease_progression 
H-positive risk:  921 902 115 869 389 135 910 355 146 61 140 57 
H-negative risk:  902 921 910 869 355 389 135 115 140 146 57 61 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 26 2 

clinical_engagement 
diagnosis 
demography 
63 new agents 
18 
disease_progression 
H-positive risk:  921 902 116 875 389 135 903 352 146 62 140 59 
H-negative risk:  902 921 903 875 352 389 135 116 140 146 59 62 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 26 3 

clinical_engagement 
diagnosis 
demography 
47 new agents 
19 
disease_progression 
H-positive risk:  922 905 119 876 389 135 901 350 144 61 140 58 
H-negative risk:  905 922 901 876 350 389 135 119 140 144 58 61 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 28 3 

clinical_engagement 
diagnosis 
demography 
73 new agents 
20 
disease_progression 
H-positive risk:  931 907 122 870 380 134 906 348 145 61 138 58 
H-negative risk:  907 931 906 870 348 380 134 122 138 145 58 61 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 29 3 

clinical_engagement 
diagnosis 
demography 
81 new agents 
21 
disease_progression 
H-positive risk:  936 911 121 871 374 132 909 345 141 61 140 59 
H-negative risk:  911 936 909 871 345 374 132 121 140 141 59 61 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 29 3 

clinical_engagement 
diagnosis 
demography 
64 new agents 
22 
disease_progression 
H-positive risk:  946 912 121 869 373 134 904 343 139 58 141 60 
H-negative risk:  912 946 904 869 343 373 134 121 141 139 60 58 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 29 6 

clinical_engagement 
diagnosis 
demography 
68 new agents 
23 
disease_progression 
H-positive risk:  955 913 124 862 368 134 913 340 136 57 139 59 
H-negative risk:  913 955 913 862 340 368 134 124 139 136 59 57 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 29 7 

clinical_engagement 
diagnosis 
demography 
51 new agents 
24 
disease_progression 
H-positive risk:  953 910 126 863 365 132 923 337 137 58 137 59 
H-negative risk:  910 953 923 863 337 365 132 126 137 137 59 58 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 28 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
25 
disease_progression 
H-positive risk:  874 822 115 955 363 119 1004 334 147 58 149 60 
H-negative risk:  822 874 1004 955 334 363 119 115 149 147 60 58 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 26 5 

clinical_engagement 
diagnosis 
demography 
168 new agents 
26 
disease_progression 
H-positive risk:  889 845 117 927 364 125 965 361 142 65 143 57 
H-negative risk:  845 889 965 927 361 364 125 117 143 142 57 65 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 27 8 

clinical_engagement 
diagnosis 
demography 
62 new agents 
27 
disease_progression 
H-positive risk:  893 852 117 922 364 128 961 357 138 63 146 59 
H-negative risk:  852 893 961 922 357 364 128 117 146 138 59 63 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 28 8 

clinical_engagement 
diagnosis 
demography 
61 new agents 
28 
disease_progression 
H-positive risk:  897 857 117 922 363 128 957 358 135 61 146 59 
H-negative risk:  857 897 957 922 358 363 128 117 146 135 59 61 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 32 8 

clinical_engagement 
diagnosis 
demography 
58 new agents 
29 
disease_progression 
H-positive risk:  896 855 118 921 363 132 957 358 136 61 145 58 
H-negative risk:  855 896 957 921 358 363 132 118 145 136 58 61 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 31 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
30 
disease_progression 
H-positive risk:  896 861 117 918 362 134 962 359 133 58 142 58 
H-negative risk:  861 896 962 918 359 362 134 117 142 133 58 58 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 32 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
31 
disease_progression 
H-positive risk:  900 861 118 923 365 137 955 354 130 56 141 60 
H-negative risk:  861 900 955 923 354 365 137 118 141 130 60 56 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 33 7 

clinical_engagement 
diagnosis 
demography 
67 new agents 
32 
disease_progression 
H-positive risk:  906 861 119 920 365 136 965 346 126 57 139 60 
H-negative risk:  861 906 965 920 346 365 136 119 139 126 60 57 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 33 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
33 
disease_progression 
H-positive risk:  908 864 121 919 357 133 971 345 124 58 140 60 
H-negative risk:  864 908 971 919 345 357 133 121 140 124 60 58 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 36 7 

clinical_engagement 
diagnosis 
demography 
56 new agents 
34 
disease_progression 
H-positive risk:  900 871 123 923 355 133 973 343 122 58 142 57 
H-negative risk:  871 900 973 923 343 355 133 123 142 122 57 58 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 36 8 

clinical_engagement 
diagnosis 
demography 
62 new agents 
35 
disease_progression 
H-positive risk:  906 874 126 924 348 131 975 342 120 56 142 56 
H-negative risk:  874 906 975 924 342 348 131 126 142 120 56 56 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 39 8 

clinical_engagement 
diagnosis 
demography 
69 new agents 
36 
disease_progression 
H-positive risk:  907 874 128 924 349 133 978 334 125 53 141 54 
H-negative risk:  874 907 978 924 334 349 133 128 141 125 54 53 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 40 8 

clinical_engagement 
diagnosis 
demography 
71 new agents 
37 
disease_progression 
H-positive risk:  848 799 118 989 350 129 1050 339 130 51 146 51 
H-negative risk:  799 848 1050 989 339 350 129 118 146 130 51 51 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 40 9 

clinical_engagement 
diagnosis 
demography 
136 new agents 
38 
disease_progression 
H-positive risk:  855 813 120 974 339 128 1029 362 129 49 146 56 
H-negative risk:  813 855 1029 974 362 339 128 120 146 129 56 49 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 41 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
39 
disease_progression 
H-positive risk:  862 819 121 971 337 130 1023 369 126 47 139 56 
H-negative risk:  819 862 1023 971 369 337 130 121 139 126 56 47 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 40 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
40 
disease_progression 
H-positive risk:  868 820 122 972 335 129 1022 363 128 46 139 56 
H-negative risk:  820 868 1022 972 363 335 129 122 139 128 56 46 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 40 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
41 
disease_progression 
H-positive risk:  872 829 121 963 332 129 1015 365 131 46 141 56 
H-negative risk:  829 872 1015 963 365 332 129 121 141 131 56 46 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 41 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
42 
disease_progression 
H-positive risk:  878 827 121 959 334 128 1011 365 129 47 145 56 
H-negative risk:  827 878 1011 959 365 334 128 121 145 129 56 47 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 42 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
43 
disease_progression 
H-positive risk:  880 827 120 961 332 133 1011 363 128 46 143 56 
H-negative risk:  827 880 1011 961 363 332 133 120 143 128 56 46 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 41 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
44 
disease_progression 
H-positive risk:  875 829 120 952 339 136 1011 368 128 46 141 55 
H-negative risk:  829 875 1011 952 368 339 136 120 141 128 55 46 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 42 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
45 
disease_progression 
H-positive risk:  877 831 121 951 338 138 1008 368 128 45 141 54 
H-negative risk:  831 877 1008 951 368 338 138 121 141 128 54 45 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 45 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
46 
disease_progression 
H-positive risk:  874 834 122 950 338 139 1007 370 128 44 139 55 
H-negative risk:  834 874 1007 950 370 338 139 122 139 128 55 44 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 48 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
47 
disease_progression 
H-positive risk:  877 833 123 948 338 140 1007 364 129 46 140 55 
H-negative risk:  833 877 1007 948 364 338 140 123 140 129 55 46 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 52 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
48 
disease_progression 
H-positive risk:  884 839 122 949 334 141 1000 363 129 46 140 53 
H-negative risk:  839 884 1000 949 363 334 141 122 140 129 53 46 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 51 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
49 
disease_progression 
H-positive risk:  825 789 114 1005 333 136 1058 364 130 47 145 54 
H-negative risk:  789 825 1058 1005 364 333 136 114 145 130 54 47 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 49 19 

clinical_engagement 
diagnosis 
demography 
127 new agents 
50 
disease_progression 
H-positive risk:  833 802 114 982 344 134 1026 384 127 55 144 55 
H-negative risk:  802 833 1026 982 384 344 134 114 144 127 55 55 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 48 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
51 
disease_progression 
H-positive risk:  837 803 113 975 348 131 1026 387 128 53 145 54 
H-negative risk:  803 837 1026 975 387 348 131 113 145 128 54 53 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 46 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
52 
disease_progression 
H-positive risk:  838 803 112 984 349 133 1021 381 126 54 145 54 
H-negative risk:  803 838 1021 984 381 349 133 112 145 126 54 54 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 45 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
53 
disease_progression 
H-positive risk:  839 809 113 978 348 132 1022 378 128 52 147 54 
H-negative risk:  809 839 1022 978 378 348 132 113 147 128 54 52 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 44 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
54 
disease_progression 
H-positive risk:  844 813 113 979 347 134 1014 372 130 51 149 54 
H-negative risk:  813 844 1014 979 372 347 134 113 149 130 54 51 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 46 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
55 
disease_progression 
H-positive risk:  851 817 110 968 350 134 1019 369 129 52 148 53 
H-negative risk:  817 851 1019 968 369 350 134 110 148 129 53 52 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 47 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
56 
disease_progression 
H-positive risk:  855 817 111 964 352 135 1018 367 127 53 148 53 
H-negative risk:  817 855 1018 964 367 352 135 111 148 127 53 53 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 49 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
57 
disease_progression 
H-positive risk:  862 820 113 968 350 133 1005 368 126 55 148 52 
H-negative risk:  820 862 1005 968 368 350 133 113 148 126 52 55 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 48 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
58 
disease_progression 
H-positive risk:  864 828 112 965 350 132 1006 360 126 56 149 52 
H-negative risk:  828 864 1006 965 360 350 132 112 149 126 52 56 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 52 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
59 
disease_progression 
H-positive risk:  865 830 113 969 347 132 1009 358 126 54 147 50 
H-negative risk:  830 865 1009 969 358 347 132 113 147 126 50 54 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 52 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
60 
disease_progression 
H-positive risk:  871 833 115 976 336 135 1001 360 128 52 143 50 
H-negative risk:  833 871 1001 976 360 336 135 115 143 128 50 52 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 55 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
61 
disease_progression 
H-positive risk:  818 796 106 1015 336 129 1050 361 135 55 152 47 
H-negative risk:  796 818 1050 1015 361 336 129 106 152 135 47 55 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 56 18 

clinical_engagement 
diagnosis 
demography 
122 new agents 
62 
disease_progression 
H-positive risk:  832 799 107 994 344 135 1030 371 135 56 142 55 
H-negative risk:  799 832 1030 994 371 344 135 107 142 135 55 56 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
63 
disease_progression 
H-positive risk:  834 815 106 983 340 137 1026 370 135 56 140 58 
H-negative risk:  815 834 1026 983 370 340 137 106 140 135 58 56 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 56 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
64 
disease_progression 
H-positive risk:  836 822 106 982 328 137 1033 364 135 56 141 60 
H-negative risk:  822 836 1033 982 364 328 137 106 141 135 60 56 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 55 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
65 
disease_progression 
H-positive risk:  838 825 106 978 329 136 1027 368 134 56 144 59 
H-negative risk:  825 838 1027 978 368 329 136 106 144 134 59 56 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 55 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
66 
disease_progression 
H-positive risk:  840 831 103 984 324 135 1023 368 133 55 143 61 
H-negative risk:  831 840 1023 984 368 324 135 103 143 133 61 55 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 63 23 

clinical_engagement 
diagnosis 
demography 
55 new agents 
67 
disease_progression 
H-positive risk:  840 823 105 980 327 134 1029 372 132 55 142 61 
H-negative risk:  823 840 1029 980 372 327 134 105 142 132 61 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
68 
disease_progression 
H-positive risk:  830 821 104 978 336 136 1031 375 132 54 143 60 
H-negative risk:  821 830 1031 978 375 336 136 104 143 132 60 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
69 
disease_progression 
H-positive risk:  829 822 106 983 334 139 1031 370 130 53 145 58 
H-negative risk:  822 829 1031 983 370 334 139 106 145 130 58 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
70 
disease_progression 
H-positive risk:  835 817 104 984 327 138 1030 372 134 53 145 61 
H-negative risk:  817 835 1030 984 372 327 138 104 145 134 61 53 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
71 
disease_progression 
H-positive risk:  831 821 106 989 324 139 1026 373 134 54 143 60 
H-negative risk:  821 831 1026 989 373 324 139 106 143 134 60 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
72 
disease_progression 
H-positive risk:  824 822 107 987 327 141 1025 378 133 55 143 58 
H-negative risk:  822 824 1025 987 378 327 141 107 143 133 58 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 64 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
73 
disease_progression 
H-positive risk:  784 761 97 1050 326 133 1057 383 144 54 151 60 
H-negative risk:  761 784 1057 1050 383 326 133 97 151 144 60 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
108 new agents 
74 
disease_progression 
H-positive risk:  792 771 97 1029 333 133 1022 422 130 59 146 66 
H-negative risk:  771 792 1022 1029 422 333 133 97 146 130 66 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
75 
disease_progression 
H-positive risk:  791 779 101 1026 332 128 1029 413 132 60 142 67 
H-negative risk:  779 791 1029 1026 413 332 128 101 142 132 67 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
76 
disease_progression 
H-positive risk:  790 776 103 1029 332 128 1029 411 131 61 143 67 
H-negative risk:  776 790 1029 1029 411 332 128 103 143 131 67 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
77 
disease_progression 
H-positive risk:  788 780 103 1027 330 129 1032 412 131 58 144 66 
H-negative risk:  780 788 1032 1027 412 330 129 103 144 131 66 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
78 
disease_progression 
H-positive risk:  796 779 103 1028 324 133 1023 414 131 59 144 66 
H-negative risk:  779 796 1023 1028 414 324 133 103 144 131 66 59 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
79 
disease_progression 
H-positive risk:  802 781 104 1030 322 136 1019 410 130 59 141 66 
H-negative risk:  781 802 1019 1030 410 322 136 104 141 130 66 59 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 66 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
80 
disease_progression 
H-positive risk:  803 779 104 1032 322 134 1013 417 130 59 142 65 
H-negative risk:  779 803 1013 1032 417 322 134 104 142 130 65 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
81 
disease_progression 
H-positive risk:  801 783 101 1034 315 134 1020 420 126 58 144 64 
H-negative risk:  783 801 1020 1034 420 315 134 101 144 126 64 58 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
82 
disease_progression 
H-positive risk:  801 786 102 1033 317 134 1019 416 127 59 143 63 
H-negative risk:  786 801 1019 1033 416 317 134 102 143 127 63 59 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
83 
disease_progression 
H-positive risk:  807 777 106 1046 315 138 1014 405 127 58 145 62 
H-negative risk:  777 807 1014 1046 405 315 138 106 145 127 62 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
84 
disease_progression 
H-positive risk:  814 769 106 1047 315 136 1016 401 129 57 149 61 
H-negative risk:  769 814 1016 1047 401 315 136 106 149 129 61 57 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 64 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
85 
disease_progression 
H-positive risk:  764 720 104 1095 316 131 1059 405 136 56 151 63 
H-negative risk:  720 764 1059 1095 405 316 131 104 151 136 63 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
121 new agents 
86 
disease_progression 
H-positive risk:  766 735 106 1068 333 130 1053 410 128 59 149 63 
H-negative risk:  735 766 1053 1068 410 333 130 106 149 128 63 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
87 
disease_progression 
H-positive risk:  768 739 103 1074 329 130 1061 397 128 61 148 62 
H-negative risk:  739 768 1061 1074 397 329 130 103 148 128 62 61 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
88 
disease_progression 
H-positive risk:  767 742 105 1076 327 130 1058 394 132 61 147 61 
H-negative risk:  742 767 1058 1076 394 327 130 105 147 132 61 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
89 
disease_progression 
H-positive risk:  763 736 103 1079 328 128 1059 402 132 59 149 62 
H-negative risk:  736 763 1059 1079 402 328 128 103 149 132 62 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
90 
disease_progression 
H-positive risk:  762 733 101 1080 331 123 1066 399 135 60 147 63 
H-negative risk:  733 762 1066 1080 399 331 123 101 147 135 63 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
91 
disease_progression 
H-positive risk:  755 736 100 1074 336 126 1073 397 136 60 146 61 
H-negative risk:  736 755 1073 1074 397 336 126 100 146 136 61 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
92 
disease_progression 
H-positive risk:  752 731 102 1071 339 127 1070 402 138 60 145 63 
H-negative risk:  731 752 1070 1071 402 339 127 102 145 138 63 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
93 
disease_progression 
H-positive risk:  754 728 102 1066 339 127 1070 406 141 60 145 62 
H-negative risk:  728 754 1070 1066 406 339 127 102 145 141 62 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
94 
disease_progression 
H-positive risk:  754 739 100 1062 332 130 1076 403 140 57 147 60 
H-negative risk:  739 754 1076 1062 403 332 130 100 147 140 60 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
95 
disease_progression 
H-positive risk:  748 740 99 1066 329 132 1075 402 138 64 148 59 
H-negative risk:  740 748 1075 1066 402 329 132 99 148 138 59 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
96 
disease_progression 
H-positive risk:  755 743 100 1058 336 133 1072 396 140 65 145 57 
H-negative risk:  743 755 1072 1058 396 336 133 100 145 140 57 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
61 new agents 
97 
disease_progression 
H-positive risk:  708 706 97 1105 339 122 1111 392 151 62 150 57 
H-negative risk:  706 708 1111 1105 392 339 122 97 150 151 57 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
98 
disease_progression 
H-positive risk:  706 701 97 1084 362 119 1100 412 152 60 145 62 
H-negative risk:  701 706 1100 1084 412 362 119 97 145 152 62 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
99 
disease_progression 
H-positive risk:  704 702 97 1090 364 117 1092 415 153 62 143 61 
H-negative risk:  702 704 1092 1090 415 364 117 97 143 153 61 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
51 new agents 
100 
disease_progression 
H-positive risk:  700 700 94 1096 354 117 1097 418 152 61 151 60 
H-negative risk:  700 700 1097 1096 418 354 117 94 151 152 60 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
101 
disease_progression 
H-positive risk:  704 699 95 1091 355 114 1104 412 152 64 150 60 
H-negative risk:  699 704 1104 1091 412 355 114 95 150 152 60 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
102 
disease_progression 
H-positive risk:  701 697 97 1096 359 115 1098 412 152 64 153 56 
H-negative risk:  697 701 1098 1096 412 359 115 97 153 152 56 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
103 
disease_progression 
H-positive risk:  705 699 99 1091 355 118 1100 402 151 69 153 58 
H-negative risk:  699 705 1100 1091 402 355 118 99 153 151 58 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
104 
disease_progression 
H-positive risk:  707 694 99 1087 356 121 1105 403 151 69 152 56 
H-negative risk:  694 707 1105 1087 403 356 121 99 152 151 56 69 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
105 
disease_progression 
H-positive risk:  707 703 99 1088 355 117 1104 404 150 70 149 54 
H-negative risk:  703 707 1104 1088 404 355 117 99 149 150 54 70 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
106 
disease_progression 
H-positive risk:  699 695 102 1095 352 118 1105 405 155 69 150 55 
H-negative risk:  695 699 1105 1095 405 352 118 102 150 155 55 69 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
107 
disease_progression 
H-positive risk:  698 697 103 1102 354 119 1098 399 156 69 151 54 
H-negative risk:  697 698 1098 1102 399 354 119 103 151 156 54 69 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
108 
disease_progression 
H-positive risk:  703 701 103 1104 357 116 1083 403 163 67 149 51 
H-negative risk:  701 703 1083 1104 403 357 116 103 149 163 51 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
109 
disease_progression 
H-positive risk:  665 665 98 1137 356 116 1124 400 166 67 157 49 
H-negative risk:  665 665 1124 1137 400 356 116 98 157 166 49 67 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
114 new agents 
110 
disease_progression 
H-positive risk:  670 659 100 1114 378 113 1118 403 168 70 153 54 
H-negative risk:  659 670 1118 1114 403 378 113 100 153 168 54 70 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
111 
disease_progression 
H-positive risk:  670 660 99 1120 375 110 1121 401 168 69 152 55 
H-negative risk:  660 670 1121 1120 401 375 110 99 152 168 55 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
112 
disease_progression 
H-positive risk:  677 652 98 1121 383 110 1118 398 169 69 152 53 
H-negative risk:  652 677 1118 1121 398 383 110 98 152 169 53 69 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
113 
disease_progression 
H-positive risk:  671 655 99 1128 378 113 1121 393 166 68 154 54 
H-negative risk:  655 671 1121 1128 393 378 113 99 154 166 54 68 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
114 
disease_progression 
H-positive risk:  672 657 100 1129 373 111 1123 394 167 68 152 54 
H-negative risk:  657 672 1123 1129 394 373 111 100 152 167 54 68 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
115 
disease_progression 
H-positive risk:  672 657 98 1125 373 112 1118 397 170 71 150 57 
H-negative risk:  657 672 1118 1125 397 373 112 98 150 170 57 71 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
116 
disease_progression 
H-positive risk:  673 660 98 1121 368 114 1127 394 168 70 151 56 
H-negative risk:  660 673 1127 1121 394 368 114 98 151 168 56 70 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 61 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
117 
disease_progression 
H-positive risk:  676 666 96 1119 364 114 1120 399 169 69 154 54 
H-negative risk:  666 676 1120 1119 399 364 114 96 154 169 54 69 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 61 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
118 
disease_progression 
H-positive risk:  680 669 95 1125 365 114 1109 401 170 67 152 53 
H-negative risk:  669 680 1109 1125 401 365 114 95 152 170 53 67 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 63 22 

clinical_engagement 
diagnosis 
demography 
89 new agents 
119 
disease_progression 
H-positive risk:  675 677 92 1127 362 112 1107 407 168 67 155 51 
H-negative risk:  677 675 1107 1127 407 362 112 92 155 168 51 67 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
120 
disease_progression 
H-positive risk:  679 678 91 1128 355 113 1117 401 167 65 155 51 
H-negative risk:  678 679 1117 1128 401 355 113 91 155 167 51 65 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
121 
disease_progression 
H-positive risk:  637 641 87 1164 357 107 1163 396 174 64 158 52 
H-negative risk:  641 637 1163 1164 396 357 107 87 158 174 52 64 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
106 new agents 
122 
disease_progression 
H-positive risk:  641 636 87 1164 364 104 1161 402 174 60 153 54 
H-negative risk:  636 641 1161 1164 402 364 104 87 153 174 54 60 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
123 
disease_progression 
H-positive risk:  641 633 85 1169 357 106 1164 412 175 57 150 51 
H-negative risk:  633 641 1164 1169 412 357 106 85 150 175 51 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
124 
disease_progression 
H-positive risk:  654 629 84 1173 359 104 1146 415 176 60 149 51 
H-negative risk:  629 654 1146 1173 415 359 104 84 149 176 51 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
125 
disease_progression 
H-positive risk:  661 634 85 1166 357 103 1140 415 180 60 149 50 
H-negative risk:  634 661 1140 1166 415 357 103 85 149 180 50 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
126 
disease_progression 
H-positive risk:  660 635 89 1171 356 103 1145 402 181 58 148 52 
H-negative risk:  635 660 1145 1171 402 356 103 89 148 181 52 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
127 
disease_progression 
H-positive risk:  663 641 89 1158 356 102 1145 407 180 58 148 53 
H-negative risk:  641 663 1145 1158 407 356 102 89 148 180 53 58 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
128 
disease_progression 
H-positive risk:  667 646 90 1160 358 100 1139 399 180 59 147 55 
H-negative risk:  646 667 1139 1160 399 358 100 90 147 180 55 59 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
129 
disease_progression 
H-positive risk:  669 636 89 1168 356 98 1141 403 179 61 146 54 
H-negative risk:  636 669 1141 1168 403 356 98 89 146 179 54 61 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
130 
disease_progression 
H-positive risk:  663 638 90 1168 362 95 1138 405 182 60 146 53 
H-negative risk:  638 663 1138 1168 405 362 95 90 146 182 53 60 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
131 
disease_progression 
H-positive risk:  668 640 93 1172 360 97 1134 400 179 58 146 53 
H-negative risk:  640 668 1134 1172 400 360 97 93 146 179 53 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
132 
disease_progression 
H-positive risk:  664 641 92 1176 360 96 1130 405 179 58 143 56 
H-negative risk:  641 664 1130 1176 405 360 96 92 143 179 56 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
133 
disease_progression 
H-positive risk:  668 643 89 1171 357 96 1136 402 178 58 144 58 
H-negative risk:  643 668 1136 1171 402 357 96 89 144 178 58 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
97 new agents 
134 
disease_progression 
H-positive risk:  663 638 87 1160 375 96 1130 412 173 62 144 60 
H-negative risk:  638 663 1130 1160 412 375 96 87 144 173 60 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
135 
disease_progression 
H-positive risk:  662 646 86 1157 371 95 1132 416 173 58 145 59 
H-negative risk:  646 662 1132 1157 416 371 95 86 145 173 59 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
136 
disease_progression 
H-positive risk:  665 641 86 1150 375 96 1136 420 171 55 144 61 
H-negative risk:  641 665 1136 1150 420 375 96 86 144 171 61 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
137 
disease_progression 
H-positive risk:  666 651 85 1145 375 93 1130 420 175 56 142 62 
H-negative risk:  651 666 1130 1145 420 375 93 85 142 175 62 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
138 
disease_progression 
H-positive risk:  668 652 83 1152 375 93 1130 410 174 57 145 61 
H-negative risk:  652 668 1130 1152 410 375 93 83 145 174 61 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
139 
disease_progression 
H-positive risk:  668 652 82 1154 371 89 1133 403 175 60 148 65 
H-negative risk:  652 668 1133 1154 403 371 89 82 148 175 65 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
140 
disease_progression 
H-positive risk:  669 655 83 1160 364 84 1133 399 176 62 150 65 
H-negative risk:  655 669 1133 1160 399 364 84 83 150 176 65 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
141 
disease_progression 
H-positive risk:  672 655 85 1159 361 85 1132 400 174 64 149 64 
H-negative risk:  655 672 1132 1159 400 361 85 85 149 174 64 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
142 
disease_progression 
H-positive risk:  670 656 85 1162 359 86 1137 396 171 63 150 65 
H-negative risk:  656 670 1137 1162 396 359 86 85 150 171 65 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
143 
disease_progression 
H-positive risk:  667 657 84 1160 359 88 1141 397 170 65 147 65 
H-negative risk:  657 667 1141 1160 397 359 88 84 147 170 65 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
144 
disease_progression 
H-positive risk:  662 656 84 1160 356 91 1147 403 167 64 150 60 
H-negative risk:  656 662 1147 1160 403 356 91 84 150 167 60 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
145 
disease_progression 
H-positive risk:  665 660 80 1158 359 90 1136 408 171 65 151 57 
H-negative risk:  660 665 1136 1158 408 359 90 80 151 171 57 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
146 
disease_progression 
H-positive risk:  665 666 81 1145 367 90 1128 421 166 64 150 57 
H-negative risk:  666 665 1128 1145 421 367 90 81 150 166 57 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
147 
disease_progression 
H-positive risk:  668 671 84 1154 368 92 1120 417 160 63 147 56 
H-negative risk:  671 668 1120 1154 417 368 92 84 147 160 56 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
148 
disease_progression 
H-positive risk:  675 668 90 1147 358 92 1123 421 157 66 148 55 
H-negative risk:  668 675 1123 1147 421 358 92 90 148 157 55 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
149 
disease_progression 
H-positive risk:  675 682 91 1136 366 92 1116 415 159 66 148 54 
H-negative risk:  682 675 1116 1136 415 366 92 91 148 159 54 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
150 
disease_progression 
H-positive risk:  679 683 93 1137 362 89 1119 410 159 67 147 55 
H-negative risk:  683 679 1119 1137 410 362 89 93 147 159 55 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
151 
disease_progression 
H-positive risk:  679 687 93 1126 365 87 1115 415 162 65 149 57 
H-negative risk:  687 679 1115 1126 415 365 87 93 149 162 57 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
152 
disease_progression 
H-positive risk:  681 683 94 1136 362 87 1126 407 159 67 147 51 
H-negative risk:  683 681 1126 1136 407 362 87 94 147 159 51 67 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
153 
disease_progression 
H-positive risk:  684 691 95 1133 363 88 1126 397 160 65 148 50 
H-negative risk:  691 684 1126 1133 397 363 88 95 148 160 50 65 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
71 new agents 
154 
disease_progression 
H-positive risk:  681 693 94 1129 363 86 1129 400 163 67 147 48 
H-negative risk:  693 681 1129 1129 400 363 86 94 147 163 48 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
155 
disease_progression 
H-positive risk:  681 694 92 1124 355 85 1135 408 166 68 145 47 
H-negative risk:  694 681 1135 1124 408 355 85 92 145 166 47 68 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
156 
disease_progression 
H-positive risk:  679 692 94 1124 357 85 1133 408 165 66 149 48 
H-negative risk:  692 679 1133 1124 408 357 85 94 149 165 48 66 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
70 new agents 
157 
disease_progression 
H-positive risk:  680 689 92 1120 364 85 1135 403 165 69 152 46 
H-negative risk:  689 680 1135 1120 403 364 85 92 152 165 46 69 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
89 new agents 
158 
disease_progression 
H-positive risk:  677 686 93 1095 376 84 1138 417 163 73 153 45 
H-negative risk:  686 677 1138 1095 417 376 84 93 153 163 45 73 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
159 
disease_progression 
H-positive risk:  679 682 92 1096 383 83 1129 418 169 71 150 48 
H-negative risk:  682 679 1129 1096 418 383 83 92 150 169 48 71 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
160 
disease_progression 
H-positive risk:  680 685 94 1086 384 81 1134 423 168 68 150 47 
H-negative risk:  685 680 1134 1086 423 384 81 94 150 168 47 68 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
161 
disease_progression 
H-positive risk:  677 678 94 1095 385 80 1137 424 168 66 148 48 
H-negative risk:  678 677 1137 1095 424 385 80 94 148 168 48 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
162 
disease_progression 
H-positive risk:  677 683 95 1097 379 81 1143 419 168 67 145 46 
H-negative risk:  683 677 1143 1097 419 379 81 95 145 168 46 67 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
163 
disease_progression 
H-positive risk:  676 679 95 1098 381 80 1151 418 165 65 147 45 
H-negative risk:  679 676 1151 1098 418 381 80 95 147 165 45 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
87 new agents 
164 
disease_progression 
H-positive risk:  674 678 97 1096 381 82 1148 421 163 66 147 47 
H-negative risk:  678 674 1148 1096 421 381 82 97 147 163 47 66 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 85 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
165 
disease_progression 
H-positive risk:  678 680 95 1092 377 83 1150 416 167 64 150 48 
H-negative risk:  680 678 1150 1092 416 377 83 95 150 167 48 64 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 86 33 

clinical_engagement 
diagnosis 
demography 
65 new agents 
166 
disease_progression 
H-positive risk:  680 677 94 1095 378 81 1151 416 166 64 150 48 
H-negative risk:  677 680 1151 1095 416 378 81 94 150 166 48 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
167 
disease_progression 
H-positive risk:  681 674 95 1104 372 79 1146 415 168 65 153 48 
H-negative risk:  674 681 1146 1104 415 372 79 95 153 168 48 65 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
168 
disease_progression 
H-positive risk:  683 674 93 1101 371 76 1141 422 166 65 159 49 
H-negative risk:  674 683 1141 1101 422 371 76 93 159 166 49 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
169 
disease_progression 
H-positive risk:  680 671 95 1097 374 74 1147 419 169 65 159 50 
H-negative risk:  671 680 1147 1097 419 374 74 95 159 169 50 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
94 new agents 
170 
disease_progression 
H-positive risk:  686 667 95 1102 379 74 1132 428 166 63 155 53 
H-negative risk:  667 686 1132 1102 428 379 74 95 155 166 53 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
89 new agents 
171 
disease_progression 
H-positive risk:  691 658 95 1110 385 76 1132 422 165 61 152 53 
H-negative risk:  658 691 1132 1110 422 385 76 95 152 165 53 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
172 
disease_progression 
H-positive risk:  695 664 95 1104 389 73 1122 425 168 57 152 56 
H-negative risk:  664 695 1122 1104 425 389 73 95 152 168 56 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
54 new agents 
173 
disease_progression 
H-positive risk:  697 664 96 1109 387 68 1122 426 170 58 150 53 
H-negative risk:  664 697 1122 1109 426 387 68 96 150 170 53 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
174 
disease_progression 
H-positive risk:  696 669 97 1102 386 70 1124 425 170 58 149 54 
H-negative risk:  669 696 1124 1102 425 386 70 97 149 170 54 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
175 
disease_progression 
H-positive risk:  696 672 98 1095 391 68 1128 420 170 60 148 54 
H-negative risk:  672 696 1128 1095 420 391 68 98 148 170 54 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
176 
disease_progression 
H-positive risk:  699 670 99 1097 381 68 1138 419 170 59 145 55 
H-negative risk:  670 699 1138 1097 419 381 68 99 145 170 55 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
79 new agents 
177 
disease_progression 
H-positive risk:  703 668 96 1101 377 68 1138 423 168 58 147 53 
H-negative risk:  668 703 1138 1101 423 377 68 96 147 168 53 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
54 new agents 
178 
disease_progression 
H-positive risk:  699 664 94 1093 387 67 1140 429 165 59 148 55 
H-negative risk:  664 699 1140 1093 429 387 67 94 148 165 55 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
179 
disease_progression 
H-positive risk:  699 673 93 1088 387 67 1142 422 165 59 149 56 
H-negative risk:  673 699 1142 1088 422 387 67 93 149 165 56 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
180 
disease_progression 
H-positive risk:  710 664 94 1090 388 69 1133 418 166 58 152 58 
H-negative risk:  664 710 1133 1090 418 388 69 94 152 166 58 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
181 
disease_progression 
H-positive risk:  699 660 95 1092 389 67 1143 415 168 57 153 62 
H-negative risk:  660 699 1143 1092 415 389 67 95 153 168 62 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
88 new agents 
182 
disease_progression 
H-positive risk:  692 656 95 1079 398 68 1152 421 168 60 152 59 
H-negative risk:  656 692 1152 1079 421 398 68 95 152 168 59 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
60 new agents 
183 
disease_progression 
H-positive risk:  685 654 90 1076 401 66 1164 420 167 61 158 58 
H-negative risk:  654 685 1164 1076 420 401 66 90 158 167 58 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
184 
disease_progression 
H-positive risk:  680 664 87 1077 401 67 1164 415 167 58 162 58 
H-negative risk:  664 680 1164 1077 415 401 67 87 162 167 58 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
58 new agents 
185 
disease_progression 
H-positive risk:  675 663 85 1083 397 68 1164 421 167 56 162 59 
H-negative risk:  663 675 1164 1083 421 397 68 85 162 167 59 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 80 34 

clinical_engagement 
diagnosis 
demography 
70 new agents 
186 
disease_progression 
H-positive risk:  679 661 83 1082 392 69 1167 422 168 55 159 63 
H-negative risk:  661 679 1167 1082 422 392 69 83 159 168 63 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
187 
disease_progression 
H-positive risk:  681 658 83 1080 390 69 1172 419 171 53 162 62 
H-negative risk:  658 681 1172 1080 419 390 69 83 162 171 62 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
188 
disease_progression 
H-positive risk:  680 655 84 1082 384 70 1165 429 172 53 164 62 
H-negative risk:  655 680 1165 1082 429 384 70 84 164 172 62 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
189 
disease_progression 
H-positive risk:  682 664 83 1081 386 70 1160 429 169 53 162 61 
H-negative risk:  664 682 1160 1081 429 386 70 83 162 169 61 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 72 34 

clinical_engagement 
diagnosis 
demography 
70 new agents 
190 
disease_progression 
H-positive risk:  687 662 83 1074 392 69 1155 436 169 53 160 60 
H-negative risk:  662 687 1155 1074 436 392 69 83 160 169 60 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 73 35 

clinical_engagement 
diagnosis 
demography 
66 new agents 
191 
disease_progression 
H-positive risk:  687 662 81 1066 408 70 1146 435 169 53 163 60 
H-negative risk:  662 687 1146 1066 435 408 70 81 163 169 60 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
192 
disease_progression 
H-positive risk:  684 670 82 1067 414 70 1149 428 167 49 159 61 
H-negative risk:  670 684 1149 1067 428 414 70 82 159 167 61 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 73 37 

clinical_engagement 
diagnosis 
demography 
76 new agents 
193 
disease_progression 
H-positive risk:  686 666 87 1070 416 69 1152 421 162 49 162 60 
H-negative risk:  666 686 1152 1070 421 416 69 87 162 162 60 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 72 40 

clinical_engagement 
diagnosis 
demography 
99 new agents 
194 
disease_progression 
H-positive risk:  695 661 83 1067 421 71 1139 433 156 52 163 59 
H-negative risk:  661 695 1139 1067 433 421 71 83 163 156 59 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 70 40 

clinical_engagement 
diagnosis 
demography 
75 new agents 
195 
disease_progression 
H-positive risk:  701 661 81 1069 421 73 1133 435 155 50 161 60 
H-negative risk:  661 701 1133 1069 435 421 73 81 161 155 60 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 68 40 

clinical_engagement 
diagnosis 
demography 
75 new agents 
196 
disease_progression 
H-positive risk:  695 653 85 1075 421 74 1127 436 157 51 164 62 
H-negative risk:  653 695 1127 1075 436 421 74 85 164 157 62 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 65 40 

clinical_engagement 
diagnosis 
demography 
72 new agents 
197 
disease_progression 
H-positive risk:  698 651 85 1072 423 75 1125 438 157 51 164 61 
H-negative risk:  651 698 1125 1072 438 423 75 85 164 157 61 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 64 40 

clinical_engagement 
diagnosis 
demography 
63 new agents 
198 
disease_progression 
H-positive risk:  683 659 84 1072 429 76 1126 438 157 53 163 60 
H-negative risk:  659 683 1126 1072 438 429 76 84 163 157 60 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 62 40 

clinical_engagement 
diagnosis 
demography 
78 new agents 
199 
disease_progression 
H-positive risk:  681 651 87 1079 429 73 1131 435 161 53 163 57 
H-negative risk:  651 681 1131 1079 435 429 73 87 163 161 57 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 62 40 

clinical_engagement 
diagnosis 
demography 
65 new agents 
200 
disease_progression 
H-positive risk:  677 647 87 1077 432 77 1134 436 158 56 158 61 
H-negative risk:  647 677 1134 1077 436 432 77 87 158 158 61 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 63 40 

clinical_engagement 
diagnosis 
demography 
86 new agents 
201 
disease_progression 
H-positive risk:  681 646 87 1090 430 76 1134 425 158 56 157 60 
H-negative risk:  646 681 1134 1090 425 430 76 87 157 158 60 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 63 39 

clinical_engagement 
diagnosis 
demography 
82 new agents 
202 
disease_progression 
H-positive risk:  688 649 87 1089 433 78 1122 421 160 56 158 59 
H-negative risk:  649 688 1122 1089 421 433 78 87 158 160 59 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 64 39 

clinical_engagement 
diagnosis 
demography 
80 new agents 
203 
disease_progression 
H-positive risk:  692 657 85 1082 431 75 1127 417 164 56 156 58 
H-negative risk:  657 692 1127 1082 417 431 75 85 156 164 58 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 66 37 

clinical_engagement 
diagnosis 
demography 
61 new agents 
204 
disease_progression 
H-positive risk:  691 648 85 1084 430 77 1126 423 167 57 154 58 
H-negative risk:  648 691 1126 1084 423 430 77 85 154 167 58 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 70 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
205 
disease_progression 
H-positive risk:  694 651 82 1085 435 78 1117 422 166 56 153 61 
H-negative risk:  651 694 1117 1085 422 435 78 82 153 166 61 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 72 35 

clinical_engagement 
diagnosis 
demography 
84 new agents 
206 
disease_progression 
H-positive risk:  695 656 80 1072 435 80 1111 434 166 56 153 62 
H-negative risk:  656 695 1111 1072 434 435 80 80 153 166 62 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
91 new agents 
207 
disease_progression 
H-positive risk:  694 664 83 1076 420 79 1112 430 166 58 156 62 
H-negative risk:  664 694 1112 1076 430 420 79 83 156 166 62 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
208 
disease_progression 
H-positive risk:  689 674 81 1060 428 80 1122 424 166 59 153 64 
H-negative risk:  674 689 1122 1060 424 428 80 81 153 166 64 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
209 
disease_progression 
H-positive risk:  680 681 85 1059 421 81 1125 427 163 62 152 64 
H-negative risk:  681 680 1125 1059 427 421 81 85 152 163 64 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
210 
disease_progression 
H-positive risk:  687 685 87 1059 412 82 1122 425 167 63 150 61 
H-negative risk:  685 687 1122 1059 425 412 82 87 150 167 61 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
211 
disease_progression 
H-positive risk:  690 684 86 1065 407 85 1113 428 169 63 153 57 
H-negative risk:  684 690 1113 1065 428 407 85 86 153 169 57 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
212 
disease_progression 
H-positive risk:  691 681 88 1072 405 85 1114 426 168 62 155 53 
H-negative risk:  681 691 1114 1072 426 405 85 88 155 168 53 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
213 
disease_progression 
H-positive risk:  691 684 86 1082 401 83 1115 426 168 61 152 51 
H-negative risk:  684 691 1115 1082 426 401 83 86 152 168 51 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
64 new agents 
214 
disease_progression 
H-positive risk:  685 686 85 1085 410 85 1112 425 165 61 152 49 
H-negative risk:  686 685 1112 1085 425 410 85 85 152 165 49 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
62 new agents 
215 
disease_progression 
H-positive risk:  680 676 83 1093 407 84 1121 423 164 64 158 47 
H-negative risk:  676 680 1121 1093 423 407 84 83 158 164 47 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
216 
disease_progression 
H-positive risk:  683 670 82 1086 412 86 1137 416 160 64 156 48 
H-negative risk:  670 683 1137 1086 416 412 86 82 156 160 48 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
87 new agents 
217 
disease_progression 
H-positive risk:  687 674 84 1078 418 84 1111 435 153 72 150 54 
H-negative risk:  674 687 1111 1078 435 418 84 84 150 153 54 72 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
218 
disease_progression 
H-positive risk:  685 674 85 1087 402 80 1122 436 154 72 148 55 
H-negative risk:  674 685 1122 1087 436 402 80 85 148 154 55 72 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 74 35 

clinical_engagement 
diagnosis 
demography 
74 new agents 
219 
disease_progression 
H-positive risk:  686 668 85 1072 413 82 1117 444 154 71 151 57 
H-negative risk:  668 686 1117 1072 444 413 82 85 151 154 57 71 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 74 35 

clinical_engagement 
diagnosis 
demography 
86 new agents 
220 
disease_progression 
H-positive risk:  684 666 85 1068 407 88 1126 440 155 71 151 59 
H-negative risk:  666 684 1126 1068 440 407 88 85 151 155 59 71 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 70 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
221 
disease_progression 
H-positive risk:  686 671 84 1069 410 88 1116 442 155 71 152 56 
H-negative risk:  671 686 1116 1069 442 410 88 84 152 155 56 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
222 
disease_progression 
H-positive risk:  692 668 82 1072 418 90 1116 427 155 70 154 56 
H-negative risk:  668 692 1116 1072 427 418 90 82 154 155 56 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
223 
disease_progression 
H-positive risk:  689 663 83 1061 417 93 1119 440 156 68 153 58 
H-negative risk:  663 689 1119 1061 440 417 93 83 153 156 58 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
82 new agents 
224 
disease_progression 
H-positive risk:  682 664 82 1062 409 97 1133 440 155 64 153 59 
H-negative risk:  664 682 1133 1062 440 409 97 82 153 155 59 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
225 
disease_progression 
H-positive risk:  671 673 83 1059 413 97 1133 444 154 62 154 57 
H-negative risk:  673 671 1133 1059 444 413 97 83 154 154 57 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
226 
disease_progression 
H-positive risk:  673 670 85 1059 416 99 1128 446 153 58 153 60 
H-negative risk:  670 673 1128 1059 446 416 99 85 153 153 60 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
227 
disease_progression 
H-positive risk:  674 671 87 1058 418 100 1118 451 152 58 154 59 
H-negative risk:  671 674 1118 1058 451 418 100 87 154 152 59 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
228 
disease_progression 
H-positive risk:  675 674 89 1062 417 97 1115 443 159 59 151 59 
H-negative risk:  674 675 1115 1062 443 417 97 89 151 159 59 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
63 new agents 
229 
disease_progression 
H-positive risk:  670 675 90 1059 422 97 1110 450 160 60 149 58 
H-negative risk:  675 670 1110 1059 450 422 97 90 149 160 58 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
88 new agents 
230 
disease_progression 
H-positive risk:  665 679 86 1055 432 99 1116 433 159 63 155 58 
H-negative risk:  679 665 1116 1055 433 432 99 86 155 159 58 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
231 
disease_progression 
H-positive risk:  671 673 86 1048 437 100 1117 431 159 62 158 58 
H-negative risk:  673 671 1117 1048 431 437 100 86 158 159 58 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
232 
disease_progression 
H-positive risk:  677 678 84 1054 436 98 1119 423 156 60 160 55 
H-negative risk:  678 677 1119 1054 423 436 98 84 160 156 55 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
233 
disease_progression 
H-positive risk:  676 678 82 1050 435 96 1127 418 157 62 163 56 
H-negative risk:  678 676 1127 1050 418 435 96 82 163 157 56 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
234 
disease_progression 
H-positive risk:  676 673 82 1063 433 95 1123 414 160 58 165 58 
H-negative risk:  673 676 1123 1063 414 433 95 82 165 160 58 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
91 new agents 
235 
disease_progression 
H-positive risk:  678 682 84 1057 425 95 1120 413 161 58 170 57 
H-negative risk:  682 678 1120 1057 413 425 95 84 170 161 57 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
236 
disease_progression 
H-positive risk:  675 678 84 1061 422 94 1125 417 158 60 170 56 
H-negative risk:  678 675 1125 1061 417 422 94 84 170 158 56 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
237 
disease_progression 
H-positive risk:  676 677 86 1069 418 93 1127 416 154 60 167 57 
H-negative risk:  677 676 1127 1069 416 418 93 86 167 154 57 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
238 
disease_progression 
H-positive risk:  680 677 88 1065 409 92 1132 416 156 62 165 58 
H-negative risk:  677 680 1132 1065 416 409 92 88 165 156 58 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
239 
disease_progression 
H-positive risk:  683 686 87 1062 411 94 1126 410 152 64 163 62 
H-negative risk:  686 683 1126 1062 410 411 94 87 163 152 62 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
240 
disease_progression 
H-positive risk:  686 684 85 1058 412 97 1121 419 151 63 164 60 
H-negative risk:  684 686 1121 1058 419 412 97 85 164 151 60 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
91 new agents 
241 
disease_progression 
H-positive risk:  696 678 87 1045 422 99 1101 434 150 65 160 63 
H-negative risk:  678 696 1101 1045 434 422 99 87 160 150 63 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
242 
disease_progression 
H-positive risk:  694 685 89 1044 421 96 1106 433 148 64 157 63 
H-negative risk:  685 694 1106 1044 433 421 96 89 157 148 63 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
243 
disease_progression 
H-positive risk:  698 689 91 1051 421 100 1098 427 147 62 154 62 
H-negative risk:  689 698 1098 1051 427 421 100 91 154 147 62 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
63 new agents 
244 
disease_progression 
H-positive risk:  692 682 93 1057 419 101 1101 433 146 64 151 61 
H-negative risk:  682 692 1101 1057 433 419 101 93 151 146 61 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
245 
disease_progression 
H-positive risk:  691 678 94 1056 423 104 1098 428 148 64 152 64 
H-negative risk:  678 691 1098 1056 428 423 104 94 152 148 64 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
246 
disease_progression 
H-positive risk:  682 684 94 1058 424 107 1098 426 147 66 149 65 
H-negative risk:  684 682 1098 1058 426 424 107 94 149 147 65 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
247 
disease_progression 
H-positive risk:  681 684 94 1058 430 105 1093 423 148 65 151 68 
H-negative risk:  684 681 1093 1058 423 430 105 94 151 148 68 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
92 new agents 
248 
disease_progression 
H-positive risk:  683 689 91 1066 431 106 1091 413 147 63 148 72 
H-negative risk:  689 683 1091 1066 413 431 106 91 148 147 72 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
249 
disease_progression 
H-positive risk:  675 686 87 1061 429 109 1103 414 148 62 155 71 
H-negative risk:  686 675 1103 1061 414 429 109 87 155 148 71 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
70 new agents 
250 
disease_progression 
H-positive risk:  670 692 88 1051 432 108 1106 416 147 63 154 73 
H-negative risk:  692 670 1106 1051 416 432 108 88 154 147 73 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
52 new agents 
251 
disease_progression 
H-positive risk:  668 688 87 1054 428 108 1107 425 147 63 152 73 
H-negative risk:  688 668 1107 1054 425 428 108 87 152 147 73 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 80 35 

clinical_engagement 
diagnosis 
demography 
69 new agents 
252 
disease_progression 
H-positive risk:  666 679 87 1058 429 107 1108 431 147 62 153 73 
H-negative risk:  679 666 1108 1058 431 429 107 87 153 147 73 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 84 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
253 
disease_progression 
H-positive risk:  670 683 90 1050 436 106 1101 432 147 57 155 73 
H-negative risk:  683 670 1101 1050 432 436 106 90 155 147 73 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 80 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
254 
disease_progression 
H-positive risk:  673 684 93 1050 424 102 1104 434 151 54 158 73 
H-negative risk:  684 673 1104 1050 434 424 102 93 158 151 73 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
87 new agents 
255 
disease_progression 
H-positive risk:  673 680 92 1046 427 103 1105 435 156 50 160 73 
H-negative risk:  680 673 1105 1046 435 427 103 92 160 156 73 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
65 new agents 
256 
disease_progression 
H-positive risk:  678 685 91 1042 425 103 1104 435 155 49 162 71 
H-negative risk:  685 678 1104 1042 435 425 103 91 162 155 71 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
257 
disease_progression 
H-positive risk:  681 679 92 1052 421 105 1092 441 152 50 164 71 
H-negative risk:  679 681 1092 1052 441 421 105 92 164 152 71 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
258 
disease_progression 
H-positive risk:  675 677 91 1055 427 102 1099 438 151 50 165 70 
H-negative risk:  677 675 1099 1055 438 427 102 91 165 151 70 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
259 
disease_progression 
H-positive risk:  674 675 89 1051 435 101 1099 444 149 48 162 73 
H-negative risk:  675 674 1099 1051 444 435 101 89 162 149 73 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
260 
disease_progression 
H-positive risk:  665 675 91 1054 438 99 1093 455 148 51 160 71 
H-negative risk:  675 665 1093 1054 455 438 99 91 160 148 71 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
261 
disease_progression 
H-positive risk:  664 673 96 1053 444 98 1085 456 152 50 160 69 
H-negative risk:  673 664 1085 1053 456 444 98 96 160 152 69 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
262 
disease_progression 
H-positive risk:  666 675 96 1044 453 99 1081 454 149 51 161 71 
H-negative risk:  675 666 1081 1044 454 453 99 96 161 149 71 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
263 
disease_progression 
H-positive risk:  670 679 95 1045 455 97 1076 451 147 52 161 72 
H-negative risk:  679 670 1076 1045 451 455 97 95 161 147 72 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
90 new agents 
264 
disease_progression 
H-positive risk:  679 677 95 1045 461 96 1072 444 148 50 162 71 
H-negative risk:  677 679 1072 1045 444 461 96 95 162 148 71 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
265 
disease_progression 
H-positive risk:  678 678 93 1041 455 97 1076 444 149 51 164 74 
H-negative risk:  678 678 1076 1041 444 455 97 93 164 149 74 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
266 
disease_progression 
H-positive risk:  673 681 96 1045 455 97 1079 443 146 52 164 69 
H-negative risk:  681 673 1079 1045 443 455 97 96 164 146 69 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
267 
disease_progression 
H-positive risk:  683 675 95 1038 463 100 1066 445 145 50 169 71 
H-negative risk:  675 683 1066 1038 445 463 100 95 169 145 71 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
268 
disease_progression 
H-positive risk:  679 678 97 1043 460 101 1064 449 145 50 163 71 
H-negative risk:  678 679 1064 1043 449 460 101 97 163 145 71 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
269 
disease_progression 
H-positive risk:  683 683 98 1033 462 104 1065 448 143 51 162 68 
H-negative risk:  683 683 1065 1033 448 462 104 98 162 143 68 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
270 
disease_progression 
H-positive risk:  679 690 96 1033 462 104 1060 449 146 50 163 68 
H-negative risk:  690 679 1060 1033 449 462 104 96 163 146 68 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
271 
disease_progression 
H-positive risk:  681 692 97 1036 462 108 1060 440 145 50 164 65 
H-negative risk:  692 681 1060 1036 440 462 108 97 164 145 65 50 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
272 
disease_progression 
H-positive risk:  685 696 95 1034 461 109 1059 440 146 50 165 60 
H-negative risk:  696 685 1059 1034 440 461 109 95 165 146 60 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
273 
disease_progression 
H-positive risk:  681 696 94 1025 471 108 1058 443 148 50 165 61 
H-negative risk:  696 681 1058 1025 443 471 108 94 165 148 61 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
274 
disease_progression 
H-positive risk:  678 701 94 1027 468 106 1064 445 147 49 163 58 
H-negative risk:  701 678 1064 1027 445 468 106 94 163 147 58 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
275 
disease_progression 
H-positive risk:  673 700 96 1033 461 107 1071 445 147 45 159 63 
H-negative risk:  700 673 1071 1033 445 461 107 96 159 147 63 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
53 new agents 
276 
disease_progression 
H-positive risk:  673 701 96 1029 465 108 1065 447 143 50 158 65 
H-negative risk:  701 673 1065 1029 447 465 108 96 158 143 65 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
277 
disease_progression 
H-positive risk:  676 699 95 1015 482 108 1061 446 142 53 157 66 
H-negative risk:  699 676 1061 1015 446 482 108 95 157 142 66 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
278 
disease_progression 
H-positive risk:  679 697 97 1015 481 112 1065 434 140 53 161 66 
H-negative risk:  697 679 1065 1015 434 481 112 97 161 140 66 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
279 
disease_progression 
H-positive risk:  675 694 102 1017 479 112 1070 436 141 51 159 64 
H-negative risk:  694 675 1070 1017 436 479 112 102 159 141 64 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
280 
disease_progression 
H-positive risk:  676 688 100 1017 476 109 1073 439 144 53 160 65 
H-negative risk:  688 676 1073 1017 439 476 109 100 160 144 65 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
281 
disease_progression 
H-positive risk:  678 688 100 1011 476 106 1082 437 143 55 159 65 
H-negative risk:  688 678 1082 1011 437 476 106 100 159 143 65 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
282 
disease_progression 
H-positive risk:  688 687 100 1005 479 106 1073 439 148 55 157 63 
H-negative risk:  687 688 1073 1005 439 479 106 100 157 148 63 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
283 
disease_progression 
H-positive risk:  685 684 100 999 486 107 1072 438 150 56 159 64 
H-negative risk:  684 685 1072 999 438 486 107 100 159 150 64 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
284 
disease_progression 
H-positive risk:  679 693 96 997 489 106 1074 431 152 56 162 65 
H-negative risk:  693 679 1074 997 431 489 106 96 162 152 65 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
285 
disease_progression 
H-positive risk:  686 686 95 1003 500 109 1064 429 152 54 160 62 
H-negative risk:  686 686 1064 1003 429 500 109 95 160 152 62 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
286 
disease_progression 
H-positive risk:  684 689 99 1001 491 111 1065 430 152 52 161 65 
H-negative risk:  689 684 1065 1001 430 491 111 99 161 152 65 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
287 
disease_progression 
H-positive risk:  688 688 96 1002 484 111 1071 422 155 51 164 68 
H-negative risk:  688 688 1071 1002 422 484 111 96 164 155 68 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
288 
disease_progression 
H-positive risk:  691 690 96 1008 482 110 1068 417 157 48 163 70 
H-negative risk:  690 691 1068 1008 417 482 110 96 163 157 70 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
289 
disease_progression 
H-positive risk:  698 685 95 1010 483 110 1069 417 156 48 162 67 
H-negative risk:  685 698 1069 1010 417 483 110 95 162 156 67 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
96 new agents 
290 
disease_progression 
H-positive risk:  691 690 91 1030 475 111 1059 416 158 47 166 66 
H-negative risk:  690 691 1059 1030 416 475 111 91 166 158 66 47 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
291 
disease_progression 
H-positive risk:  685 696 88 1022 473 107 1071 415 167 45 164 67 
H-negative risk:  696 685 1071 1022 415 473 107 88 164 167 67 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
292 
disease_progression 
H-positive risk:  684 701 89 1023 463 106 1070 415 168 47 164 70 
H-negative risk:  701 684 1070 1023 415 463 106 89 164 168 70 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
293 
disease_progression 
H-positive risk:  688 695 91 1031 451 108 1063 418 169 47 165 74 
H-negative risk:  695 688 1063 1031 418 451 108 91 165 169 74 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
294 
disease_progression 
H-positive risk:  682 702 88 1026 458 103 1067 421 168 49 165 71 
H-negative risk:  702 682 1067 1026 421 458 103 88 165 168 71 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
295 
disease_progression 
H-positive risk:  681 697 89 1020 462 101 1072 421 171 51 165 70 
H-negative risk:  697 681 1072 1020 421 462 101 89 165 171 70 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
296 
disease_progression 
H-positive risk:  681 693 89 1029 453 99 1072 422 174 55 164 69 
H-negative risk:  693 681 1072 1029 422 453 99 89 164 174 69 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
297 
disease_progression 
H-positive risk:  678 687 95 1034 460 101 1069 418 173 55 161 69 
H-negative risk:  687 678 1069 1034 418 460 101 95 161 173 69 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
298 
disease_progression 
H-positive risk:  680 682 97 1039 449 101 1074 424 173 54 159 68 
H-negative risk:  682 680 1074 1039 424 449 101 97 159 173 68 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
299 
disease_progression 
H-positive risk:  684 679 99 1032 456 100 1068 431 172 54 157 68 
H-negative risk:  679 684 1068 1032 431 456 100 99 157 172 68 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
300 
disease_progression 
H-positive risk:  677 682 102 1037 453 100 1070 425 172 56 157 69 
H-negative risk:  682 677 1070 1037 425 453 100 102 157 172 69 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
301 
disease_progression 
H-positive risk:  667 688 102 1042 442 104 1083 420 172 56 157 67 
H-negative risk:  688 667 1083 1042 420 442 104 102 157 172 67 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
302 
disease_progression 
H-positive risk:  673 688 101 1043 445 103 1087 409 168 58 155 70 
H-negative risk:  688 673 1087 1043 409 445 103 101 155 168 70 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
303 
disease_progression 
H-positive risk:  668 681 101 1048 442 100 1094 412 168 60 153 73 
H-negative risk:  681 668 1094 1048 412 442 100 101 153 168 73 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
304 
disease_progression 
H-positive risk:  669 685 100 1049 437 102 1087 417 167 63 152 72 
H-negative risk:  685 669 1087 1049 417 437 102 100 152 167 72 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
305 
disease_progression 
H-positive risk:  674 696 100 1053 427 99 1088 410 167 62 153 71 
H-negative risk:  696 674 1088 1053 410 427 99 100 153 167 71 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
306 
disease_progression 
H-positive risk:  668 692 99 1058 433 100 1090 408 165 63 152 72 
H-negative risk:  692 668 1090 1058 408 433 100 99 152 165 72 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
307 
disease_progression 
H-positive risk:  669 696 99 1060 419 100 1100 404 168 61 153 71 
H-negative risk:  696 669 1100 1060 404 419 100 99 153 168 71 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
91 new agents 
308 
disease_progression 
H-positive risk:  671 706 100 1072 411 100 1101 399 169 54 151 66 
H-negative risk:  706 671 1101 1072 399 411 100 100 151 169 66 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
309 
disease_progression 
H-positive risk:  671 699 101 1072 412 101 1103 399 168 54 150 70 
H-negative risk:  699 671 1103 1072 399 412 101 101 150 168 70 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
310 
disease_progression 
H-positive risk:  671 700 100 1077 411 98 1096 404 166 55 155 67 
H-negative risk:  700 671 1096 1077 404 411 98 100 155 166 67 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
311 
disease_progression 
H-positive risk:  671 703 98 1078 408 102 1102 398 166 53 155 66 
H-negative risk:  703 671 1102 1078 398 408 102 98 155 166 66 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
312 
disease_progression 
H-positive risk:  675 708 98 1075 412 105 1093 393 164 54 154 69 
H-negative risk:  708 675 1093 1075 393 412 105 98 154 164 69 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
313 
disease_progression 
H-positive risk:  679 700 92 1089 413 104 1087 393 163 55 158 67 
H-negative risk:  700 679 1087 1089 393 413 104 92 158 163 67 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
314 
disease_progression 
H-positive risk:  675 701 93 1092 411 102 1082 391 169 56 161 67 
H-negative risk:  701 675 1082 1092 391 411 102 93 161 169 67 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
315 
disease_progression 
H-positive risk:  681 707 95 1080 406 103 1075 394 169 58 161 71 
H-negative risk:  707 681 1075 1080 394 406 103 95 161 169 71 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
316 
disease_progression 
H-positive risk:  683 699 92 1086 406 102 1072 397 176 56 160 71 
H-negative risk:  699 683 1072 1086 397 406 102 92 160 176 71 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
317 
disease_progression 
H-positive risk:  682 698 92 1076 415 100 1072 402 178 54 159 72 
H-negative risk:  698 682 1072 1076 402 415 100 92 159 178 72 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
318 
disease_progression 
H-positive risk:  671 697 97 1076 411 102 1089 402 175 55 159 66 
H-negative risk:  697 671 1089 1076 402 411 102 97 159 175 66 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
319 
disease_progression 
H-positive risk:  672 688 98 1086 407 102 1082 410 174 54 161 66 
H-negative risk:  688 672 1082 1086 410 407 102 98 161 174 66 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
320 
disease_progression 
H-positive risk:  675 688 96 1087 407 105 1085 405 173 56 157 66 
H-negative risk:  688 675 1085 1087 405 407 105 96 157 173 66 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
321 
disease_progression 
H-positive risk:  681 691 98 1090 395 103 1081 400 178 52 164 67 
H-negative risk:  691 681 1081 1090 400 395 103 98 164 178 67 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
322 
disease_progression 
H-positive risk:  682 682 99 1096 399 107 1069 403 179 53 163 68 
H-negative risk:  682 682 1069 1096 403 399 107 99 163 179 68 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
323 
disease_progression 
H-positive risk:  679 679 97 1100 396 108 1076 400 180 53 165 67 
H-negative risk:  679 679 1076 1100 400 396 108 97 165 180 67 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
92 new agents 
324 
disease_progression 
H-positive risk:  678 692 99 1090 393 110 1078 397 176 54 163 70 
H-negative risk:  692 678 1078 1090 397 393 110 99 163 176 70 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
325 
disease_progression 
H-positive risk:  682 693 95 1089 395 108 1080 393 179 54 163 69 
H-negative risk:  693 682 1080 1089 393 395 108 95 163 179 69 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
326 
disease_progression 
H-positive risk:  678 700 97 1087 389 107 1086 391 182 50 164 69 
H-negative risk:  700 678 1086 1087 391 389 107 97 164 182 69 50 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
327 
disease_progression 
H-positive risk:  686 692 101 1096 384 105 1075 399 181 47 164 70 
H-negative risk:  692 686 1075 1096 399 384 105 101 164 181 70 47 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
328 
disease_progression 
H-positive risk:  688 693 104 1095 384 106 1068 403 178 48 164 69 
H-negative risk:  693 688 1068 1095 403 384 106 104 164 178 69 48 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
91 new agents 
329 
disease_progression 
H-positive risk:  685 688 104 1099 377 104 1078 403 176 47 168 71 
H-negative risk:  688 685 1078 1099 403 377 104 104 168 176 71 47 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
330 
disease_progression 
H-positive risk:  679 700 103 1089 379 103 1082 402 178 47 169 69 
H-negative risk:  700 679 1082 1089 402 379 103 103 169 178 69 47 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
331 
disease_progression 
H-positive risk:  679 701 101 1094 383 102 1085 394 178 46 171 66 
H-negative risk:  701 679 1085 1094 394 383 102 101 171 178 66 46 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
332 
disease_progression 
H-positive risk:  674 705 101 1095 391 102 1087 386 178 47 168 66 
H-negative risk:  705 674 1087 1095 386 391 102 101 168 178 66 47 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
333 
disease_progression 
H-positive risk:  665 700 100 1103 395 102 1086 390 179 46 166 68 
H-negative risk:  700 665 1086 1103 390 395 102 100 166 179 68 46 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
334 
disease_progression 
H-positive risk:  664 708 100 1098 398 103 1077 394 180 44 166 68 
H-negative risk:  708 664 1077 1098 394 398 103 100 166 180 68 44 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
335 
disease_progression 
H-positive risk:  664 710 100 1103 395 103 1080 394 177 43 164 67 
H-negative risk:  710 664 1080 1103 394 395 103 100 164 177 67 43 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 73 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
336 
disease_progression 
H-positive risk:  662 713 99 1100 398 99 1076 397 181 42 163 70 
H-negative risk:  713 662 1076 1100 397 398 99 99 163 181 70 42 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
337 
disease_progression 
H-positive risk:  658 718 98 1099 396 97 1089 395 181 41 161 67 
H-negative risk:  718 658 1089 1099 395 396 97 98 161 181 67 41 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
88 new agents 
338 
disease_progression 
H-positive risk:  661 716 98 1102 392 96 1089 403 176 40 162 65 
H-negative risk:  716 661 1089 1102 403 392 96 98 162 176 65 40 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 79 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
339 
disease_progression 
H-positive risk:  668 718 95 1094 401 96 1092 393 174 41 165 63 
H-negative risk:  718 668 1092 1094 393 401 96 95 165 174 63 41 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 79 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
340 
disease_progression 
H-positive risk:  666 721 91 1100 401 96 1080 401 177 40 164 63 
H-negative risk:  721 666 1080 1100 401 401 96 91 164 177 63 40 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 78 14 

clinical_engagement 
diagnosis 
demography 
92 new agents 
341 
disease_progression 
H-positive risk:  661 725 92 1104 400 95 1083 396 173 44 162 65 
H-negative risk:  725 661 1083 1104 396 400 95 92 162 173 65 44 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 79 13 

clinical_engagement 
diagnosis 
demography 
84 new agents 
342 
disease_progression 
H-positive risk:  665 718 92 1111 403 94 1083 390 173 44 159 68 
H-negative risk:  718 665 1083 1111 390 403 94 92 159 173 68 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 76 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
343 
disease_progression 
H-positive risk:  670 712 93 1110 405 95 1082 399 167 46 156 65 
H-negative risk:  712 670 1082 1110 399 405 95 93 156 167 65 46 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 78 13 

clinical_engagement 
diagnosis 
demography 
92 new agents 
344 
disease_progression 
H-positive risk:  673 704 93 1113 406 93 1077 400 171 47 156 67 
H-negative risk:  704 673 1077 1113 400 406 93 93 156 171 67 47 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 81 12 

clinical_engagement 
diagnosis 
demography 
83 new agents 
345 
disease_progression 
H-positive risk:  677 703 91 1105 401 95 1086 405 170 47 156 64 
H-negative risk:  703 677 1086 1105 405 401 95 91 156 170 64 47 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 77 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
346 
disease_progression 
H-positive risk:  681 703 88 1102 401 92 1085 410 169 49 154 66 
H-negative risk:  703 681 1085 1102 410 401 92 88 154 169 66 49 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 77 12 

clinical_engagement 
diagnosis 
demography 
82 new agents 
347 
disease_progression 
H-positive risk:  684 704 89 1100 400 93 1081 409 171 53 150 66 
H-negative risk:  704 684 1081 1100 409 400 93 89 150 171 66 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 77 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
348 
disease_progression 
H-positive risk:  686 701 89 1111 398 92 1073 410 170 53 150 67 
H-negative risk:  701 686 1073 1111 410 398 92 89 150 170 67 53 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 76 14 

clinical_engagement 
diagnosis 
demography 
77 new agents 
349 
disease_progression 
H-positive risk:  693 704 89 1104 404 93 1068 412 169 53 148 63 
H-negative risk:  704 693 1068 1104 412 404 93 89 148 169 63 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
350 
disease_progression 
H-positive risk:  694 698 88 1106 415 94 1067 413 164 52 149 60 
H-negative risk:  698 694 1067 1106 413 415 94 88 149 164 60 52 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
351 
disease_progression 
H-positive risk:  692 698 89 1096 417 93 1070 416 166 50 151 62 
H-negative risk:  698 692 1070 1096 416 417 93 89 151 166 62 50 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
84 new agents 
352 
disease_progression 
H-positive risk:  699 701 88 1093 417 90 1072 404 166 51 150 69 
H-negative risk:  701 699 1072 1093 404 417 90 88 150 166 69 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
87 new agents 
353 
disease_progression 
H-positive risk:  705 697 90 1104 410 91 1073 398 166 51 149 66 
H-negative risk:  697 705 1073 1104 398 410 91 90 149 166 66 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
84 new agents 
354 
disease_progression 
H-positive risk:  708 700 89 1101 406 91 1068 395 169 50 152 71 
H-negative risk:  700 708 1068 1101 395 406 91 89 152 169 71 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
355 
disease_progression 
H-positive risk:  706 704 90 1104 404 92 1063 400 164 49 153 71 
H-negative risk:  704 706 1063 1104 400 404 92 90 153 164 71 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
356 
disease_progression 
H-positive risk:  711 702 93 1100 410 91 1057 404 158 49 154 71 
H-negative risk:  702 711 1057 1100 404 410 91 93 154 158 71 49 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
92 new agents 
357 
disease_progression 
H-positive risk:  708 706 92 1098 404 93 1053 413 158 51 152 72 
H-negative risk:  706 708 1053 1098 413 404 93 92 152 158 72 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 79 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
358 
disease_progression 
H-positive risk:  705 702 92 1091 413 93 1054 415 161 50 152 72 
H-negative risk:  702 705 1054 1091 415 413 93 92 152 161 72 50 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 79 13 

clinical_engagement 
diagnosis 
demography 
76 new agents 
359 
disease_progression 
H-positive risk:  707 695 91 1097 417 94 1055 411 163 49 151 70 
H-negative risk:  695 707 1055 1097 411 417 94 91 151 163 70 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 81 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
360 
disease_progression 
H-positive risk:  701 691 92 1089 420 97 1064 417 163 48 150 68 
H-negative risk:  691 701 1064 1089 417 420 97 92 150 163 68 48 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 82 11 

clinical_engagement 
diagnosis 
demography 
62 new agents 
Time difference of 16.90985 mins
This is task 15
date
